article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

The combination of advanced long- and short-read genomic sequencing technologies holds great promise for precision oncology, and in the development of mRNA vaccines for certain cancers. The post A new dawn of the genomic age: five areas set to be transformed in 2023 appeared first on.

Genome 129
article thumbnail

Genomic projects exploit scale as clinical applications play catch-up

Pharmaceutical Technology

The group analysed 12,222 samples collected through whole genome sequencing efforts of the UK National Health Service as part of the 100,000 Genomes Project and added further data on 6,418 cancers from the International Cancer Genome Consortium and the Hartwig Medical Foundation. Both teams had the same underlying goal.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hong Kong reports 'first case' of virus reinfection

The Pharma Data

“And it should not negate the global drive to develop Covid-19 vaccines. . “This is a very rare example of reinfection,” said Brendan Wren, professor of microbial pathogenesis, at London School of Hygiene and Tropical Medicine. “It is to be expected that the virus will naturally mutate over time.”

article thumbnail

The Biotech Effect

Pharmaceutical Technology

“However, around the time of the Human Genome Project, there was a ‘land grab’ for the new technologies as big pharmaceuticals tried to catch up paying high prices to access technology platforms in areas such as genomics and high throughput screening.”

Antibody 100